A research team led by BBRF grantees has reported the first randomized, controlled trial in patients with major depressive disorder (MDD) to demonstrate that a pharmacological intervention—follow-on…
Read More
In a what could be a major step forward in depression research, a team led by BBRF grantees has reported the results of experiments that they say reveals the mechanism through which the rapid anti-…
Read More
A team of researchers has published results of experiments in patients with treatment-resistant depression that provides direct evidence of at least one important mechanism through which ketamine…
Read More
Researchers have published a highly detailed account of a mechanism through which ketamine, a rapid-acting antidepressant, alters plasticity, or the strength of connections between neurons, and in so…
Read More
Even with the development and FDA approval in recent years of the first rapid-acting antidepressant medicines—to which more than 90 BBRF grants have contributed—the search for novel depression…
Read More
